SUBSCRIBE
SUBSCRIBE
News   Drug Development

Allergy Therapeutics plc Says FDA Lifts Hold on Drug

March 28, 2011 | 
1 min read
March 28 (Reuters) - Britain's Allergy Therapeutics said U.S. health regulators would allow further development of its product that treats pollen allergy, sending its shares up 13 percent.
Clinical research Phase II
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Modern data center with AI server racks connected by glowing blue lines, representing artificial intelligence, advanced computing, and data processing.
Drug Development
If Data Is the New Oil, AI Is the Refinery
September 8, 2025
 · 
5 min read
 · 
Lori Ellis
Contemporary art collage of woman sitting in the lotus position, cloud, pillows against the background of the night sky. Concept of healthy lifestyle and sport. Good and relaxing sleep. Copy space.
Neuroscience
Alkermes One Ups Takeda in Narcolepsy, Clearing Cognitive Impairments in Mid-Stage Trial
September 8, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Blue growth graph business chart data diagram on success financial presentation background with abstract up arrow bar symbol or finance marketing price statistic and economy market profit investment.
Neuroscience
Rapport Jumps 180% on ‘Best Case’ Mid-Stage Data for Epilepsy Pill
September 8, 2025
 · 
2 min read
 · 
Heather McKenzie
Employees wonder how to evaluate job security
Lung cancer
Summit’s Keytruda Challenger Hits Cross-Country Consistency Problems, Raising US Approval Questions
September 8, 2025
 · 
2 min read
 · 
Tristan Manalac